Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Glaxosmithkline (GSK) Share News

LONDON MARKET CLOSE: FTSE 100 rises despite tariff worries; M&G shines

30th May 2025 17:05

(Alliance News) - The FTSE 100 outperformed in a mixed day for European equities, after the US Court of Appeals temporarily reinstated Donald Trump's tariffs. Read More

GSK ends cUTI trial early as Spero joint product meets efficacy goal

28th May 2025 12:16

(Alliance News) - GSK PLC on Wednesday said it will stop a late-stage trial early for an investigational oral antibiotic to treat complicated urinary tract infections, or cUTIs, after the treatment showed positive results in an interim analysis. Read More

LONDON MARKET CLOSE: Stocks down before long weekend, Powell's speech

23rd May 2025 17:01

(Alliance News) - Stock prices in London closed in the red on Friday, following US President Donald Trump's renewed tariff threats against the EU and Apple. Read More

GSK hails positive EU opinion of blood cancer treatment Blenrep

23rd May 2025 12:49

(Alliance News) - GSK PLC on Friday said its drug Blenrep has received a "positive opinion" from the European Medicines Agency's Committee for Medicinal Products for Human Use. Read More

LONDON MARKET OPEN: European stocks rise as bond yields ease

23rd May 2025 08:56

(Alliance News) - European stocks opened higher on Friday, as a cooling of US yields calmed some investor nerves, while improved UK data boosted sterling. Read More

GSK's Nucala wins FDA approval for COPD with eosinophilic inflammation

23rd May 2025 08:27

(Alliance News) - GSK PLC on Thursday said the US Food & Drug Administration has approved its asthma drug Nucala as an add-on maintenance treatment for adults with chronic obstructive pulmonary disease, or COPD, who have an eosinophilic phenotype. Read More

GSK wins approval in Japan for Blenrep combination as myeloma therapy

19th May 2025 08:20

(Alliance News) - GSK PLC on Monday said it has received approval in Japan for Blenrep combinations in the treatment of adults with relapsed or refractory multiple myeloma. Read More

LONDON MARKET CLOSE: Stocks rise amid trade de-escalation boost

16th May 2025 17:01

(Alliance News) - The FTSE 100 pushed higher on Friday, ending the week on a strong note, and now at the level it roughly stood at prior to US President Donald Trump's 'liberation day' tariff melee. Read More

LONDON MARKET MIDDAY: FTSE 100 outperforms as Europe underwhelms

15th May 2025 12:13

(Alliance News) - London's FTSE 100 outperformed European peers, though a share price fall for oil majors and a host of other shares that went ex-dividend kept a lid on the blue-chip index's progress. Read More

LONDON BROKER RATINGS: RBC cuts AB Foods; JPMorgan raises Mondi

14th May 2025 09:30

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More

GSK acquires "potential best-in-class" medicine efimosfermin

14th May 2025 09:13

(Alliance News) - GSK announced on Wednesday that it has agreed with Boston Pharmaceuticals to buy steatotic liver disease medication efimosfermin alfa. Read More

LONDON BRIEFING: Burberry swings to loss; H&T agrees terms of takeover

14th May 2025 07:53

(Alliance News) - London's FTSE was called down on Wednesday following criticisms from China on the US-UK trade deal being detrimental to third-party interests, and new threats from Europe for sanctions on Russia if a ceasefire in Ukraine is not reached. Read More

FTSE 100 Latest

Value8,772.38

Change55.93